Release 5 Preview #2

This page is part of the FHIR Specification (v4.4.0: R5 Preview #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4

Plandefinition-opioidcds-05

Clinical Decision Support Work Group

Maturity Level: N/A

Standards Status: Informative

Compartments: Not linked to any defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile PlanDefinition.

Generated Narrative with Details

id: opioidcds-05

url: http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-05

identifier: cdc-opioid-guidance (OFFICIAL)

version: 0.1.0

name: cdc-opioid-05

title: CDC Opioid Prescribing Guideline Recommendation #5

type: ECA Rule (Details : {http://terminology.hl7.org/CodeSystem/plan-definition-type code 'eca-rule' = 'ECA Rule', given as 'ECA Rule'})

status: draft

date: 2017-04-23

publisher: Centers for Disease Control and Prevention (CDC)

description: When opioids are started, providers should prescribe the lowest effective dosage.

useContext: ,

jurisdiction: United States of America (Details : {urn:iso:std:iso:3166 code 'US' = 'United States of America', given as 'United States of America'})

purpose: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage: Providers should use caution when prescribing opioids at any dosage, should carefully reassess evidence of individual benefits and risks when considering increasing dosage to ≥50 morphine milligram equivalents (MME)/day, and should avoid increasing dosage to ≥90 MME/day or carefully justify a decision to titrate dosage to >90 MME/day

topic: Opioid Prescribing (Details )

author: Kensaku Kawamoto, MD, PhD, MHS: , Bryn Rhodes: , Floyd Eisenberg, MD, MPH: , Robert McClure, MD, MPH:

relatedArtifact: ,

library: http://example.org/fhir/Library/opioidcds-recommendation-05

action
title: High risk for opioid overdose.
description: Total morphine milligram equivalent (MME) exceeds recommended amount. Taper to less than 50.
documentation:
trigger:
Conditions
- Kind Expression
* applicability
groupingBehavior: visual-group
selectionBehavior: exactly-one
dynamicValue
path: action.title
expression:
dynamicValue
path: action.description
expression:
dynamicValue
path: activity.extension
expression:
Actions
-
*
*
*
*

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.